BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23643473)

  • 1. Feasibility of applying the 2day deferral for repeat plateletpheresis: Indian perspective.
    Nomani L; Raina TR; Sidhu M
    Transfus Apher Sci; 2013 Jun; 48(3):341-3. PubMed ID: 23643473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
    Patidar GK; Sharma RR; Marwaha N
    Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
    Tondon R; Pandey P; Chaudhry R
    J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of plateletpheresis on complete blood count values using three different cell separator systems in healthy donors.
    Beyan C; Cetin T; Kaptan K; Nevruz O
    Transfus Apher Sci; 2003 Aug; 29(1):45-7. PubMed ID: 12877892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre- and post- donation haematological values in healthy donors undergoing plateletpheresis with five different systems.
    Das SS; Chaudhary R; Verma SK; Ojha S; Khetan D
    Blood Transfus; 2009 Jul; 7(3):188-92. PubMed ID: 19657482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of donor variables on yield in single donor plateletpheresis by continuous flow cell separator.
    Chaudhary R; Das SS; Khetan D; Sinha P
    Transfus Apher Sci; 2006 Apr; 34(2):157-61. PubMed ID: 16510315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching iron-deficient whole blood donors to plateletpheresis.
    O'Meara A; Infanti L; Sigle J; Stern M; Buser A
    Transfusion; 2012 Oct; 52(10):2183-8. PubMed ID: 22404849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plateletpheresis donor deferral patterns at a tertiary care hospital in North India: A need for rethink of haemoglobin cutoff.
    Sharma H; Khajuria K; Bansal N; Thakur K; Sharma A
    Transfus Clin Biol; 2023 May; 30(2):268-271. PubMed ID: 36893913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in hematological parameters post plateletpheresis: Single center study from North India.
    Rajput S; Makroo RN; Chowdhry M; Thakur UK
    Transfus Apher Sci; 2021 Dec; 60(6):103283. PubMed ID: 34625349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat plateletpheresis: the effects on the donor and the yield.
    Rock G; Tittley P; Sternbach M; Buskard N; Schroeder M
    Vox Sang; 1992; 63(2):102-6. PubMed ID: 1441301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective quality evaluation of single donor platelets (SDP) - an experience of a tertiary healthcare center in India.
    Pandey P; Tiwari AK; Sharma J; Singh MB; Dixit S; Raina V
    Transfus Apher Sci; 2012 Apr; 46(2):163-7. PubMed ID: 22365925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent platelet apheresis donations in volunteer donors with hemoglobin < 125 g/l are safe and efficient.
    Méndez A; Wägli F; Schmid I; Frey BM
    Transfus Apher Sci; 2007 Feb; 36(1):47-53. PubMed ID: 17234455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations.
    Lazarus EF; Browning J; Norman J; Oblitas J; Leitman SF
    Transfusion; 2001 Jun; 41(6):756-61. PubMed ID: 11399815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and causes of pre-donation deferrals among potential plateletpheresis donors at a blood center in Eastern China.
    Zhu H; Wang J; Lin H
    Transfus Clin Biol; 2023 May; 30(2):189-194. PubMed ID: 36257581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Era of blood component therapy: time for mandatory pre-donation platelet count for maximizing donor safety and optimizing quality of platelets.
    Das SS; Zaman RU; Biswas D
    Transfus Apher Sci; 2013 Dec; 49(3):640-3. PubMed ID: 23928130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographic, laboratory, and operational variables that influence short- and long-term plateletpheresis yields.
    Badami KG; Sesun M; Basu A; Absalom N
    J Clin Apher; 2012 Nov; 27(5):247-54. PubMed ID: 22730096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator.
    Buchholz DH; Squires JE; Herman JH; Ng AT; Anderson JK; Hedberg SL
    Transfusion; 1997 Jul; 37(7):715-8. PubMed ID: 9225935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-apheresis donor platelet count: an important platelet yield predictor.
    Saluja K; Thakral B; Sharma RR; Marwaha N
    J Clin Apher; 2006 Dec; 21(4):274. PubMed ID: 16847940
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of plateletpheresis on the Fenwal CS-3000 on donor platelet counts.
    Kalish RI; Chambers LA; Linden JV
    J Clin Apher; 1987; 3(4):230-4. PubMed ID: 3680195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.